James F. Walters

NeOnc Technologies, Inc. operates as a cancer biotechnology company, develops intranasal inhalation and other nontraditional delivery of a novel for the treatment of lung cancer, malignant brain cancer (gliomas), and other aggressive brain cancers. The company was founded by by Thomas C. Chen and Eytan J Lombroso on April 13, 2015 and is headquartered in Los Angeles, CA.

Kellogg & Andelson Accountancy Corp. engages in the provision of accounting services. The firm offers financial consulting, tax return and preparation, live bookkeeping, accounts payable, and business process evaluation services. The company was founded in 1939 and is headquartered in Woodland Hills, CA.

Kellogg & Andelson Accountancy Corp. engages in the provision of accounting services. The firm offers financial consulting, tax return and preparation, live bookkeeping, accounts payable, and business process evaluation services. The company was founded in 1939 and is headquartered in Woodland Hills, CA.

NeOnc Technologies, Inc. operates as a cancer biotechnology company, develops intranasal inhalation and other nontraditional delivery of a novel for the treatment of lung cancer, malignant brain cancer (gliomas), and other aggressive brain cancers. The company was founded by by Thomas C. Chen and Eytan J Lombroso on April 13, 2015 and is headquartered in Los Angeles, CA.

NeOnc Technologies, Inc. operates as a cancer biotechnology company, develops intranasal inhalation and other nontraditional delivery of a novel for the treatment of lung cancer, malignant brain cancer (gliomas), and other aggressive brain cancers. The company was founded by by Thomas C. Chen and Eytan J Lombroso on April 13, 2015 and is headquartered in Los Angeles, CA.